SuperworthAprea Therapeutics market cap APRE
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $6.5M
- Highest close in our data
- $1B
- Dec 2019
Aprea Therapeutics is worth $6.5M at the close on Oct 23, 2026, at $0.52 a share.
That is down 20% over the last year and down 94% over five years.
Its highest close in our data was $1B in Dec 2019.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $6.5M | $3.8M | $11.8M | +5% |
| 2025 | $6.2M | $5.9M | $22.8M | −66% |
| 2024 | $18.3M | $14.1M | $36.3M | +4% |
| 2023 | $17.6M | $10.8M | $27.8M | +0% |
| 2022 | $17.5M | $14.5M | $59.9M | −72% |
| 2021 | $61.6M | $61.6M | $154.2M | −41% |
| 2020 | $104.2M | $104.2M | $872.2M | −90% |
| 2019 | $1B | $528.5M | $1B | n/a |
Against its peers
Companies in Healthcare nearest Aprea Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| APREAprea Therapeutics | $6.5M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $52.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Aprea Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.